• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment.

作者信息

Imhof Céline, Messchendorp A Lianne, Bungener Laura B, Hepkema Bouke G, Kho Marcia M L, Reinders Marlies E J, Bemelman Frederike J, Hilbrands Luuk B, Gansevoort Ron T, Sanders Jan Stephan F

机构信息

Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Transplantation Immunology, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

出版信息

Clin Kidney J. 2024 Apr 25;17(5):sfae122. doi: 10.1093/ckj/sfae122. eCollection 2024 May.

DOI:10.1093/ckj/sfae122
PMID:38770045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11105120/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b12/11105120/e399a5c97106/sfae122fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b12/11105120/e399a5c97106/sfae122fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b12/11105120/e399a5c97106/sfae122fig1.jpg

相似文献

1
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment.2019冠状病毒病疫苗接种对终末期肾病患者肾功能和人类白细胞抗原抗体形成以及肾脏替代治疗的影响
Clin Kidney J. 2024 Apr 25;17(5):sfae122. doi: 10.1093/ckj/sfae122. eCollection 2024 May.
2
Low incidence of de novo HLA antibodies after COVID-19 vaccination: A cohort study of patients awaiting kidney transplantation.新冠疫苗接种后 HLA 抗体新生发生率低：一项等待肾移植患者的队列研究。
Transpl Infect Dis. 2023 Dec;25(6):e14105. doi: 10.1111/tid.14105. Epub 2023 Aug 31.
3
Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.慢性肾脏病、透析或肾移植患者中 SARS-CoV-2 疫苗接种的长期疗效和安全性：一项全国前瞻性观察性队列研究。
BMC Nephrol. 2022 Feb 5;23(1):55. doi: 10.1186/s12882-022-02680-3.
4
The Interplay Between Human Leukocyte Antigen Antibody Profile and COVID-19 Vaccination in Waitlisted Renal Transplant Patients.
Arch Pathol Lab Med. 2025 Jan 1;149(1):20-29. doi: 10.5858/arpa.2023-0370-OA.
5
Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination.接种 COVID-19 疫苗后，阳性流式细胞术交叉配型与抗体检测结果不一致。
Am J Transplant. 2021 Nov;21(11):3785-3789. doi: 10.1111/ajt.16753. Epub 2021 Jul 19.
6
Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation.接受肾脏替代治疗、血液透析、腹膜透析和肾移植的日本患者接种 BNT162b2 mRNA COVID-19 疫苗后的抗 SARS-CoV-2 IgG 抗体滴度。
Clin Exp Nephrol. 2023 Aug;27(8):660-671. doi: 10.1007/s10157-023-02348-8. Epub 2023 Apr 24.
7
Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients.血液透析患者对乙型肝炎病毒疫苗接种的反应性与MHC I类、II类和III类等位基因频率之间的关系。
Scand J Immunol. 1995 Jul;42(1):60-5. doi: 10.1111/j.1365-3083.1995.tb03626.x.
8
Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease.晚期慢性肾病老年患者接种第二剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗后的抗体反应比较
Ren Replace Ther. 2022;8(1):13. doi: 10.1186/s41100-022-00402-x. Epub 2022 Apr 5.
9
Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.BNT162b2 mRNA 疫苗对肾移植和慢性透析患者的影响：3-5 个月随访结果。
J Nephrol. 2022 Jan;35(1):153-164. doi: 10.1007/s40620-021-01210-y. Epub 2022 Jan 6.
10
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.人类白细胞抗原（HLA）遗传变异与 COVID-19 疫苗抗体反应和突破性结果风险的关系。
Nat Commun. 2024 May 13;15(1):4031. doi: 10.1038/s41467-024-48339-5.

本文引用的文献

1
Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial.优化免疫抑制以预防有HLA抗体的肾移植受者移植失败（OuTSMART）：一项随机对照试验
EClinicalMedicine. 2023 Jan 12;56:101819. doi: 10.1016/j.eclinm.2022.101819. eCollection 2023 Feb.
2
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.在未对两到三剂 mRNA 疫苗（RECOVAC）产生应答的肾移植受者中提高 COVID-19 疫苗免疫原性的替代策略：一项随机临床试验。
Lancet Infect Dis. 2023 Mar;23(3):307-319. doi: 10.1016/S1473-3099(22)00650-8. Epub 2022 Oct 27.
3
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.COVID-19 疫苗接种后肾移植受者排斥反应的非侵入性监测。
Front Immunol. 2022 Feb 25;13:838985. doi: 10.3389/fimmu.2022.838985. eCollection 2022.
4
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.RECOVAC 免疫反应研究：COVID-19 疫苗在慢性肾脏病、透析或肾移植患者中的免疫原性、耐受性和安全性。
Transplantation. 2022 Apr 1;106(4):821-834. doi: 10.1097/TP.0000000000003983.
5
The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.RECOVAC IR研究：mRNA-1273新冠疫苗在慢性肾病患者、接受透析患者或肾移植受者中的免疫反应及安全性
Nephrol Dial Transplant. 2021 Aug 27;36(9):1761-1764. doi: 10.1093/ndt/gfab186.